Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Mar 20, 2017, 10:07 ET Western IRB Establishes Single-IRB Solution to Help Institutions Comply with New Mandate for NIH-Funded Research

Western Institutional Review Board® (WIRB™), the world's leading provider of ethical review of clinical research, announced today the launch of its...


Mar 20, 2017, 09:25 ET PARI Pharma development featuring eFlow Technology for Bronchiolitis Obliterans Syndrome (BOS) is licensed to Breath Therapeutics

PARI Pharma, a company focused on optimization of drug-device combinations, has licensed its first-in-class inhalation development program for...


Mar 20, 2017, 09:00 ET Global Genomics Group Announces Breakthrough Diagnostic Blood Test for Plaque Detection in the Heart

Global Genomics Group ("G3"), a precision-medicine-based biopharmaceutical company developing genetically validated therapeutics and diagnostics...


Mar 20, 2017, 09:00 ET CannRx and iCAN:Israel-Cannabis Announce Formation of a Joint Venture to Market the First Advanced Sleep Cannabis Formulation: ican.sleep

CannRx together with iCAN:Israel-Cannabis announced the formation of a joint venture at CannaTech , Israel's premier medical cannabis conference....


Mar 20, 2017, 09:00 ET Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 3 and TONES 4 Studies of JZP-110 in Patients with Obstructive Sleep Apnea

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy results from two global multicenter studies in adult patients with...


Mar 20, 2017, 09:00 ET New Evidence-Based Recommendation Released From NICE (U.K.) For Lateral Interbody Fusion

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive,...


Mar 20, 2017, 08:30 ET Peer-Reviewed Paper Demonstrates the Benefits of Dropless Cataract Surgery®

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced the publication of a Dropless...


Mar 20, 2017, 08:30 ET Ampio Pharmaceuticals Provides Corporate Update

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), a leader in the development of Ampion™, a low molecular weight fraction of human serum albumin with...


Mar 20, 2017, 08:00 ET Truth or Myth? Global Survey for World Oral Health Day Exposes the Truth About our Oral Health Habits

Today on World Oral Health Day, FDI World Dental Federation is myth busting what people around the world believe to be good oral health...


Mar 20, 2017, 08:00 ET Multiple Presentations at 15th St. Gallen International Breast Cancer Conference Demonstrate Significant Impact of Oncotype DX Breast Recurrence Score® in Reducing Burden and Cost of Chemotherapy

Genomic Health, Inc. (Nasdaq: GHDX) today announced results from 15 Oncotype DX Breast Recurrence Score® studies conducted in 12 countries that...


Mar 20, 2017, 08:00 ET Audentes Therapeutics Announces Presentation Of Data From RECENSUS, A Medical Chart Review Of Patients With X-Linked Myotubular Myopathy (XLMTM)

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients...


Mar 20, 2017, 07:30 ET Palatin Technologies Receives Notice of Allowance on Bremelanotide Methods of Use Patent for Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...


Mar 20, 2017, 07:30 ET NKTR-181 Meets Primary and Secondary Endpoints in Phase 3 SUMMIT-07 Study in Chronic Pain

Nektar Therapeutics (Nasdaq: NKTR) today announced positive results from the SUMMIT-07 Phase 3 efficacy study of NKTR-181, a first-in-class opioid...


Mar 20, 2017, 07:00 ET Channel Medsystems® Completes Treatments in Largest Single-Arm Pivotal Study of Endometrial Ablation; Demonstrates Feasibility of Comfortable, Office-Based Procedure

Channel Medsystems, the developer of an innovative, physician office-based therapy for heavy menstrual bleeding, announced the successful...


Mar 20, 2017, 07:00 ET BioLineRx Provides Update on Phase 2 Open-Label Study for BL-8040 as Novel Stem Cell Mobilization Treatment

- Results to date confirm that single injection of BL-8040 mobilizes sufficient amounts of cells required for allogeneic transplantation without...


Mar 20, 2017, 06:45 ET Lilly Announces Phase 3 MONARCH 2 Breast Cancer Study of Abemaciclib Met Primary Endpoint of Progression-Free Survival

Eli Lilly and Company (NYSE: LLY) today announced that its MONARCH 2 trial of abemaciclib met the primary endpoint of progression-free survival...


Mar 20, 2017, 03:00 ET Vérité ou mythe ? Une enquête mondiale réalisée pour la Journée mondiale de la santé bucco-dentaire expose la vérité sur nos habitudes bucco-dentaires

Aujourd'hui, à l'occasion de la Journée mondiale de la santé bucco-dentaire, la Fédération dentaire internationale (FDI) détruit le mythe selon...


Mar 20, 2017, 03:00 ET Wahrheit oder Mythos? Weltweite Umfrage zum Weltmundgesundheitstag enthüllt die Wahrheit über unsere Mundpflegegewohnheiten

Am heutigen Weltmundgesundheitstag entzaubert die FDI World Dental Federation den Mythos, was Menschen weltweit für gute Mundpflege halten, und...


Mar 19, 2017, 17:00 ET Array BioPharma Provides NEMO Update

Array BioPharma Inc. (Nasdaq: ARRY) today announced that it has withdrawn from the U.S. Food and Drug Administration's (FDA) Division of Oncology...